PetVivo Holdings, through its subsidiary PetVivo, Inc., is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and other therapeutics for pets. The company believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. A key component of PetVivo’s in-licensing strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than the more stringently regulated pharmaceuticals. For more information, visit the company’s website at www.petvivo.com